Clinical Research Consltng Inc is categorized under Scientific Consultants in Orlando, FL and active since 2011.
Clinical Research Consltng Inc was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Scientific Consultants business, which does work in the B2B market, and is classified as a Scientific Consultants, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Bsn Kimes Traci Lrn at the company’s single location by writing to 10743 Narcoossee Road, Orlando, Florida FL 32832 or by phoning (407) 380-5522. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Research Consltng Inc |
| Contact Person: | Bsn Kimes Traci Lrn |
| Address: | 10743 Narcoossee Road, Orlando, Florida 32832 |
| Phone Number: | (407) 380-5522 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Scientific Consultants |
| SIC Code: | 8999 |
| NAICS Code: | 6214930 |
| Share This Business: |
Clinical Research Consltng Inc was started in 2011 to provide professional Scientific Consultants under the SIC code 8999 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Bsn Kimes Traci Lrn for inquiries that concern Clinical Research Consltng Inc by calling the company number (407) 380-5522, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Research Consltng Inc can be found at the coordinates 28.412499,-81.24284 as well as the street address 10743 Narcoossee Road in Orlando, Florida 32832.
For its online presence, you may visit Clinical Research Consltng Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.